74.70
-1.58%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About SYN-Tech Chem & Pharm Co
Its shares trade on Taipei Exchange under the ticker 1777.TWO. It has been listed since 9 April 2004. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.30bn and net income of TWD 261.6m. At that date it held total assets of TWD 2.96bn and shareholders' equity of TWD 2.59bn.
SYN-TECH Chemical & Pharmaceutical Co., Ltd. engages in the research, development, and manufacture of active pharmaceutical ingredients. The company is headquartered in Tainan, Tainan. The company went IPO on 2004-04-09. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Company’s main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. The company is also engaged in the pharmaceutical agency business. The firm distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 9 Apr 2004
- Employees
- 210
- Website
- syn-tech.com.tw ↗
Leadership
Pay as last reported
- Mr. Zhenming XiaoChairman of the Board, since 1989TWD 3.7m
- Rongbin XieDeputy General Manager
- Meiqi ZhuangHead of Finance & Accounting, Corporate Governance Officer
- Junze CaiDirector
- Shuiqing ChenDirector
- Mr. Ziting FanDirector
- Qiming ChenIndependent Director
- Yingji WangIndependent Director
- Yiyan WuIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- SYN-TECH Chemical & Pharmaceutical Co., Ltd. produces muscle relaxants and cardiovascular agents in Tainan, Taiwan.
- The company employs 210 full-time employees specializing in API manufacturing and distribution.
- SYN-TECH distributes products across Asia, Europe, the Americas, and Africa markets.
Weaknesses
- SYN-TECH's business is limited to active pharmaceutical ingredients without diversification into other sectors.
- The company's focus on APIs may restrict growth in high-demand therapeutic areas.
- SYN-TECH's operations are concentrated in Tainan, Taiwan, limiting geographic expansion.
Opportunities
- Expanding API production for cardiovascular agents in the European market offers growth potential.
- Increasing demand for antimicrobials in Asia presents new business opportunities.
- Growing pharmaceutical agency business in the Americas can boost revenue streams.
Threats
- Competition from other API manufacturers in the European market could reduce market share.
- Regulatory changes in the Asian pharmaceutical sector may impact production costs.
- Economic instability in Africa could affect export sales of pharmaceutical products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.